Diazyme Laboratories, Inc.
Mark Griffiths possesses extensive experience in the laboratory diagnostics field, currently serving as a Group Manager and R&D Scientist at Diazyme Laboratories since March 2010, leading initiatives in latex immunoassay reagent product development. Prior to this role, Mark held positions at Beckman Coulter from April 2005 to 2009, serving as a Technical Operations Scientist and a Senior Production Technician, focusing on process engineering and latex immunoassay reagent production. Mark's career began at Aalto Scientific, LTD., where responsibilities included production technician duties for calibrators and controls in clinical diagnostics from September 2003 to April 2005. Educational credentials include a Master of Business Administration with a focus on healthcare and entrepreneurship from San Diego State University (2013-2017) and a degree in Biology with a specialization in Physiology from Portland State University (1998-2002).
This person is not in any teams
Diazyme Laboratories, Inc.
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme’s products include test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, and electrolytes. Diazyme Laboratories is located in Poway, California and is a cGMP and ISO 13485 certified medical device manufacturer.